Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scheid

Showing results (1171-1180 of 1,291) with videos related to

Pageof 130
Sort By:
Nature|April 14, 2022
Prolonged viral suppression with anti-HIV-1 antibody therapyChristian Gaebler, Lilian Nogueira, Elina Stoffel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2016
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMTSilke Heidenreich, Dimitris Ziagkos, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Mycoses|December 17, 2025
Zoonotic Sporotrichosis in Paraguay: A Public Health AlertMirtha Gabriela Santacruz Silvero, Carolina Melchior do Prado, Bram Spruijtenburg, et al.
Bone Marrow Transplantation|November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTKavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Gastroenterologia Y Hepatologia|May 26, 2023
Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopyHenry Córdova, Eva Barreiro-Alonso, Edgar Castillo-Regalado, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Leukemia|July 21, 2020
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Pageof 130

Showing results (1171-1180 of 1,291) with videos related to

Sort By:
Pageof 130
Nature|April 14, 2022
Prolonged viral suppression with anti-HIV-1 antibody therapyChristian Gaebler, Lilian Nogueira, Elina Stoffel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2016
Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMTSilke Heidenreich, Dimitris Ziagkos, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTMaría Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Mycoses|December 17, 2025
Zoonotic Sporotrichosis in Paraguay: A Public Health AlertMirtha Gabriela Santacruz Silvero, Carolina Melchior do Prado, Bram Spruijtenburg, et al.
Bone Marrow Transplantation|November 12, 2024
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTKavita Raj, Diderik-Jan Eikema, Sarah Lawless, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Gastroenterologia Y Hepatologia|May 26, 2023
Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopyHenry Córdova, Eva Barreiro-Alonso, Edgar Castillo-Regalado, et al.
British Journal of Haematology|July 10, 2018
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMOIrit Avivi, Luca Arcaini, Virginia V Ferretti, et al.
Leukemia|July 21, 2020
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Pageof 130